Selected research
Market Structure
Global Anti-helminthic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-helminthic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-helminthic Drugs include Anhui Shengying Pharmaceutical Co., Ltd., Beijing Taiyang Pharmaceutical Co., Ltd., Chengdu Hengda Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Fujian Dongrui Pharmaceutical Co., Ltd., Guilin Nanyao Pharmaceutical Co., Ltd., Hubei Ruihua Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. and Jiaozuo Furuitang Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anti-helminthic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-helminthic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-helminthic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-helminthic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-helminthic Drugs Segment by Company
Anhui Shengying Pharmaceutical Co., Ltd.
Beijing Taiyang Pharmaceutical Co., Ltd.
Chengdu Hengda Pharmaceutical Co., Ltd.
Diao Group Chengdu Pharmaceutical Co., Ltd.
Fujian Dongrui Pharmaceutical Co., Ltd.
Guilin Nanyao Pharmaceutical Co., Ltd.
Hubei Ruihua Pharmaceutical Co., Ltd.
China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
Jiaozuo Furuitang Pharmaceutical Co., Ltd.
Nanjing Pharmaceutical Factory Co., Ltd.
Shaanxi Hanwang Pharmaceutical Co., Ltd.
Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
Shanghai Tengrui Pharmaceutical Co., Ltd.
Shaoxing Minsheng Pharmaceutical Co., Ltd.
Sichuan Tiande Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Zhejiang Anbet Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Anti-helminthic Drugs Segment by Type
Pyrantel Pamoate
Piperazine
Mimbendazole
Praziquantel
Albendazole
Anti-helminthic Drugs Segment by Application
For Veterinary Use
For Human Use
Anti-helminthic Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-helminthic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-helminthic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-helminthic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-helminthic Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-helminthic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-helminthic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Anti-helminthic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Anti-helminthic Drugs Industry Trends
Table 2. Anti-helminthic Drugs Industry Drivers
Table 3. Anti-helminthic Drugs Industry Opportunities and Challenges
Table 4. Anti-helminthic Drugs Industry Restraints
Table 5. Global Anti-helminthic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Anti-helminthic Drugs Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Anti-helminthic Drugs Sales by Manufacturers (K Units) & (2021-2026)
Table 8. Global Anti-helminthic Drugs Sales Market Share by Manufacturers
Table 9. Global Anti-helminthic Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026)
Table 10. Global Anti-helminthic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Anti-helminthic Drugs Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Anti-helminthic Drugs Manufacturers, Product Type & Application
Table 13. Global Anti-helminthic Drugs Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Anti-helminthic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Pyrantel Pamoate
Table 17. Major Manufacturers of Piperazine
Table 18. Major Manufacturers of Mimbendazole
Table 19. Major Manufacturers of Praziquantel
Table 20. Major Manufacturers of Albendazole
Table 21. Global Anti-helminthic Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units)
Table 22. Global Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units)
Table 23. Global Anti-helminthic Drugs Sales by Type (2027-2032) & (K Units)
Table 24. Global Anti-helminthic Drugs Sales Market Share by Type (2021-2026)
Table 25. Global Anti-helminthic Drugs Sales Market Share by Type (2027-2032)
Table 26. Global Anti-helminthic Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units)
Table 27. Global Anti-helminthic Drugs Revenue by Type (2021-2026) & (K Units)
Table 28. Global Anti-helminthic Drugs Revenue by Type (2027-2032) & (K Units)
Table 29. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2026)
Table 30. Global Anti-helminthic Drugs Revenue Market Share by Type (2027-2032)
Table 31. Major Manufacturers of For Veterinary Use
Table 32. Major Manufacturers of For Human Use
Table 33. Global Anti-helminthic Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units)
Table 34. Global Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units)
Table 35. Global Anti-helminthic Drugs Sales by Application (2027-2032) & (K Units)
Table 36. Global Anti-helminthic Drugs Sales Market Share by Application (2021-2026)
Table 37. Global Anti-helminthic Drugs Sales Market Share by Application (2027-2032)
Table 38. Global Anti-helminthic Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units)
Table 39. Global Anti-helminthic Drugs Revenue by Application (2021-2026) & (K Units)
Table 40. Global Anti-helminthic Drugs Revenue by Application (2027-2032) & (K Units)
Table 41. Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2026)
Table 42. Global Anti-helminthic Drugs Revenue Market Share by Application (2027-2032)
Table 43. Global Anti-helminthic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units)
Table 44. Global Anti-helminthic Drugs Sales by Region (2021-2026) & (K Units)
Table 45. Global Anti-helminthic Drugs Sales Market Share by Region (2021-2026)
Table 46. Global Anti-helminthic Drugs Sales Forecasted by Region (2027-2032) & (K Units)
Table 47. Global Anti-helminthic Drugs Sales Forecasted Market Share by Region (2027-2032)
Table 48. North America Anti-helminthic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 49. North America Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 50. North America Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units)
Table 51. Europe Anti-helminthic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 52. Europe Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 53. Europe Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units)
Table 54. Asia Pacific Anti-helminthic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 55. Asia Pacific Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 56. Asia Pacific Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units)
Table 57. South America, Middle East and Africa Anti-helminthic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 58. South America, Middle East and Africa Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units)
Table 59. South America, Middle East and Africa Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units)
Table 60. Global Anti-helminthic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 61. Global Anti-helminthic Drugs Revenue by Region (2021-2026) & (US$ Million)
Table 62. Global Anti-helminthic Drugs Revenue by Region (2027-2032) & (US$ Million)
Table 63. Global Anti-helminthic Drugs Revenue Market Share by Region (2021-2026)
Table 64. Global Anti-helminthic Drugs Revenue Market Share by Region (2027-2032)
Table 65. Anhui Shengying Pharmaceutical Co., Ltd. Company Information
Table 66. Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
Table 67. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 69. Anhui Shengying Pharmaceutical Co., Ltd. Recent Development
Table 70. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
Table 71. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
Table 72. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 74. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Development
Table 75. Chengdu Hengda Pharmaceutical Co., Ltd. Company Information
Table 76. Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview
Table 77. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 79. Chengdu Hengda Pharmaceutical Co., Ltd. Recent Development
Table 80. Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information
Table 81. Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview
Table 82. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 84. Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Development
Table 85. Fujian Dongrui Pharmaceutical Co., Ltd. Company Information
Table 86. Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview
Table 87. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 89. Fujian Dongrui Pharmaceutical Co., Ltd. Recent Development
Table 90. Guilin Nanyao Pharmaceutical Co., Ltd. Company Information
Table 91. Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview
Table 92. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 94. Guilin Nanyao Pharmaceutical Co., Ltd. Recent Development
Table 95. Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
Table 96. Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
Table 97. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 99. Hubei Ruihua Pharmaceutical Co., Ltd. Recent Development
Table 100. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
Table 101. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
Table 102. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 104. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Development
Table 105. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information
Table 106. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview
Table 107. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 109. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Development
Table 110. Nanjing Pharmaceutical Factory Co., Ltd. Company Information
Table 111. Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
Table 112. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 114. Nanjing Pharmaceutical Factory Co., Ltd. Recent Development
Table 115. Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
Table 116. Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview
Table 117. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 119. Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Development
Table 120. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
Table 121. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
Table 122. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 124. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Development
Table 125. Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information
Table 126. Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview
Table 127. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 129. Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Development
Table 130. Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information
Table 131. Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview
Table 132. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 134. Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Development
Table 135. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
Table 136. Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
Table 137. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 139. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Development
Table 140. Southwest Pharmaceutical Co., Ltd. Company Information
Table 141. Southwest Pharmaceutical Co., Ltd. Business Overview
Table 142. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 144. Southwest Pharmaceutical Co., Ltd. Recent Development
Table 145. Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
Table 146. Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
Table 147. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 149. Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Development
Table 150. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
Table 151. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
Table 152. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 153. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
Table 154. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development
Table 155. Key Raw Materials
Table 156. Raw Materials Key Suppliers
Table 157. Anti-helminthic Drugs Distributors List
Table 158. Anti-helminthic Drugs Customers List
Table 159. Research Programs/Design for This Report
Table 160. Authors List of This Report
Table 161. Secondary Sources
Table 162. Primary Sources
List of Figures
Figure 1. Anti-helminthic Drugs Product Image
Figure 2. Global Anti-helminthic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Anti-helminthic Drugs Market Size (2021-2032) & (US$ Million)
Figure 4. Global Anti-helminthic Drugs Sales (2021-2032) & (K Units)
Figure 5. Global Anti-helminthic Drugs Average Price (US$/Unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Anti-helminthic Drugs Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Pyrantel Pamoate Image
Figure 9. Piperazine Image
Figure 10. Mimbendazole Image
Figure 11. Praziquantel Image
Figure 12. Albendazole Image
Figure 13. Global Anti-helminthic Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 14. Global Anti-helminthic Drugs Sales Market Share 2021 VS 2025 VS 2032
Figure 15. Global Anti-helminthic Drugs Sales Market Share by Type (2021-2032)
Figure 16. Global Anti-helminthic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 17. Global Anti-helminthic Drugs Revenue Market Share 2021 VS 2025 VS 2032
Figure 18. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2032)
Figure 19. For Veterinary Use Image
Figure 20. For Human Use Image
Figure 21. Global Anti-helminthic Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 22. Global Anti-helminthic Drugs Sales Market Share 2021 VS 2025 VS 2032
Figure 23. Global Anti-helminthic Drugs Sales Market Share by Application (2021-2032)
Figure 24. Global Anti-helminthic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 25. Global Anti-helminthic Drugs Revenue Market Share 2021 VS 2025 VS 2032
Figure 26. Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2032)
Figure 27. North America Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 28. North America Anti-helminthic Drugs Sales Market Share by Country (2021-2032)
Figure 29. U.S. Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 30. Canada Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 31. Mexico Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 32. Europe Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 33. Europe Anti-helminthic Drugs Sales Market Share by Country (2021-2032)
Figure 34. Germany Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 35. France Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 36. U.K. Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 37. Italy Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 38. Netherlands Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 39. Asia Pacific Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 40. Asia Pacific Anti-helminthic Drugs Sales Market Share by Country (2021-2032)
Figure 41. China Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 42. Japan Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 43. South Korea Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 44. Southeast Asia Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 45. India Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 46. Australia Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 47. South America, Middle East and Africa Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 48. South America, Middle East and Africa Anti-helminthic Drugs Sales Market Share by Country (2021-2032)
Figure 49. Brazil Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 50. South Africa Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 51. Saudi Arabia Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 52. Turkey Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 53. Argentina Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 54. UAE Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 55. Egypt Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 56. Chile Anti-helminthic Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 57. Global Anti-helminthic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 58. Global Anti-helminthic Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 59. North America Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million)
Figure 60. North America Anti-helminthic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 61. Europe Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million)
Figure 62. Europe Anti-helminthic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 63. Asia-Pacific Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million)
Figure 64. Asia-Pacific Anti-helminthic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 65. South America, Middle East and Africa Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million)
Figure 66. South America, Middle East and Africa Anti-helminthic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 67. Anti-helminthic Drugs Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Anti-helminthic Drugs Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
Scope & coverage.
Types
- Pyrantel Pamoate
- Piperazine
- Mimbendazole
- Praziquantel
- Albendazole
Applications
- For Veterinary Use
- For Human Use
Companies covered
- Anhui Shengying Pharmaceutical Co., Ltd.
- Beijing Taiyang Pharmaceutical Co., Ltd.
- Chengdu Hengda Pharmaceutical Co., Ltd.
- Diao Group Chengdu Pharmaceutical Co., Ltd.
- Fujian Dongrui Pharmaceutical Co., Ltd.
- Guilin Nanyao Pharmaceutical Co., Ltd.
- Hubei Ruihua Pharmaceutical Co., Ltd.
- China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
- Jiaozuo Furuitang Pharmaceutical Co., Ltd.
- Nanjing Pharmaceutical Factory Co., Ltd.
- Shaanxi Hanwang Pharmaceutical Co., Ltd.
- Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
- Shanghai Tengrui Pharmaceutical Co., Ltd.
- Shaoxing Minsheng Pharmaceutical Co., Ltd.
- Sichuan Tiande Pharmaceutical Co., Ltd.
- Southwest Pharmaceutical Co., Ltd.
- Zhejiang Anbet Pharmaceutical Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Anti-helminthic Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Anti-helminthic Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Anti-helminthic Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Anti-helminthic Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Anti-helminthic Drugs Market Dynamics
- 2.1 Anti-helminthic Drugs Industry Trends
- 2.2 Anti-helminthic Drugs Industry Drivers
- 2.3 Anti-helminthic Drugs Industry Opportunities and Challenges
- 2.4 Anti-helminthic Drugs Industry Restraints
3 Anti-helminthic Drugs Market by Manufacturers
- 3.1 Global Anti-helminthic Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Anti-helminthic Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Anti-helminthic Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Anti-helminthic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anti-helminthic Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Anti-helminthic Drugs Manufacturers, Product Type & Application
- 3.7 Global Anti-helminthic Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anti-helminthic Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anti-helminthic Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Anti-helminthic Drugs Tier 1, Tier 2, and Tier 3
4 Anti-helminthic Drugs Market by Type
- 4.1 Anti-helminthic Drugs Type Introduction
- 4.1.1 Pyrantel Pamoate
- 4.1.2 Piperazine
- 4.1.3 Mimbendazole
- 4.1.4 Praziquantel
- 4.1.5 Albendazole
- 4.2 Global Anti-helminthic Drugs Sales by Type
- 4.2.1 Global Anti-helminthic Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anti-helminthic Drugs Sales by Type (2021-2032)
- 4.2.3 Global Anti-helminthic Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Anti-helminthic Drugs Revenue by Type
- 4.3.1 Global Anti-helminthic Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anti-helminthic Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2032)
5 Anti-helminthic Drugs Market by Application
- 5.1 Anti-helminthic Drugs Application Introduction
- 5.1.1 For Veterinary Use
- 5.1.2 For Human Use
- 5.2 Global Anti-helminthic Drugs Sales by Application
- 5.2.1 Global Anti-helminthic Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-helminthic Drugs Sales by Application (2021-2032)
- 5.2.3 Global Anti-helminthic Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Anti-helminthic Drugs Revenue by Application
- 5.3.1 Global Anti-helminthic Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anti-helminthic Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2032)
6 Global Anti-helminthic Drugs Sales by Region
- 6.1 Global Anti-helminthic Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anti-helminthic Drugs Sales by Region (2021-2032)
- 6.2.1 Global Anti-helminthic Drugs Sales by Region (2021-2026)
- 6.2.2 Global Anti-helminthic Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Anti-helminthic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Anti-helminthic Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Anti-helminthic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Anti-helminthic Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Anti-helminthic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Anti-helminthic Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Anti-helminthic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Anti-helminthic Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Anti-helminthic Drugs Revenue by Region
- 7.1 Global Anti-helminthic Drugs Revenue by Region
- 7.1.1 Global Anti-helminthic Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Anti-helminthic Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Anti-helminthic Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Anti-helminthic Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Anti-helminthic Drugs Revenue (2021-2032)
- 7.2.2 North America Anti-helminthic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Anti-helminthic Drugs Revenue (2021-2032)
- 7.3.2 Europe Anti-helminthic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Anti-helminthic Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Anti-helminthic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Anti-helminthic Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Anti-helminthic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Anhui Shengying Pharmaceutical Co., Ltd.
- 8.1.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
- 8.1.2 Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
- 8.1.3 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.1.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments
- 8.2 Beijing Taiyang Pharmaceutical Co., Ltd.
- 8.2.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
- 8.2.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
- 8.2.3 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.2.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
- 8.3 Chengdu Hengda Pharmaceutical Co., Ltd.
- 8.3.1 Chengdu Hengda Pharmaceutical Co., Ltd. Company Information
- 8.3.2 Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.3.5 Chengdu Hengda Pharmaceutical Co., Ltd. Recent Developments
- 8.4 Diao Group Chengdu Pharmaceutical Co., Ltd.
- 8.4.1 Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information
- 8.4.2 Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview
- 8.4.3 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.4.5 Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Developments
- 8.5 Fujian Dongrui Pharmaceutical Co., Ltd.
- 8.5.1 Fujian Dongrui Pharmaceutical Co., Ltd. Company Information
- 8.5.2 Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview
- 8.5.3 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.5.5 Fujian Dongrui Pharmaceutical Co., Ltd. Recent Developments
- 8.6 Guilin Nanyao Pharmaceutical Co., Ltd.
- 8.6.1 Guilin Nanyao Pharmaceutical Co., Ltd. Company Information
- 8.6.2 Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview
- 8.6.3 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.6.5 Guilin Nanyao Pharmaceutical Co., Ltd. Recent Developments
- 8.7 Hubei Ruihua Pharmaceutical Co., Ltd.
- 8.7.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
- 8.7.2 Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
- 8.7.3 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.7.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments
- 8.8 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
- 8.8.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
- 8.8.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
- 8.8.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.8.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments
- 8.9 Jiaozuo Furuitang Pharmaceutical Co., Ltd.
- 8.9.1 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information
- 8.9.2 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview
- 8.9.3 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.9.5 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Developments
- 8.10 Nanjing Pharmaceutical Factory Co., Ltd.
- 8.10.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
- 8.10.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
- 8.10.3 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.10.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
- 8.11 Shaanxi Hanwang Pharmaceutical Co., Ltd.
- 8.11.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
- 8.11.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview
- 8.11.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.11.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments
- 8.12 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
- 8.12.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
- 8.12.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
- 8.12.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.12.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
- 8.13 Shanghai Tengrui Pharmaceutical Co., Ltd.
- 8.13.1 Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information
- 8.13.2 Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview
- 8.13.3 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.13.5 Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Developments
- 8.14 Shaoxing Minsheng Pharmaceutical Co., Ltd.
- 8.14.1 Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information
- 8.14.2 Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview
- 8.14.3 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.14.5 Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Developments
- 8.15 Sichuan Tiande Pharmaceutical Co., Ltd.
- 8.15.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
- 8.15.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
- 8.15.3 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.15.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
- 8.16 Southwest Pharmaceutical Co., Ltd.
- 8.16.1 Southwest Pharmaceutical Co., Ltd. Company Information
- 8.16.2 Southwest Pharmaceutical Co., Ltd. Business Overview
- 8.16.3 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.16.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
- 8.17 Zhejiang Anbet Pharmaceutical Co., Ltd.
- 8.17.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
- 8.17.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
- 8.17.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.17.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments
- 8.18 Zhejiang Hisun Pharmaceutical Co., Ltd.
- 8.18.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
- 8.18.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
- 8.18.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 8.18.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anti-helminthic Drugs Value Chain Analysis
- 9.1.1 Anti-helminthic Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anti-helminthic Drugs Production Mode & Process
- 9.2 Anti-helminthic Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anti-helminthic Drugs Distributors
- 9.2.3 Anti-helminthic Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst